Vasculitis & polymyalgia rheumatica

Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides

Rheumatology (Oxford)Published Prospective cross-sectional biomarker study

Authors' conclusion

mtDNA, unlike nDNA, is elevated in the plasma of AAV patients and may contribute to systemic inflammation.

Study context

Population
Consecutive patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) (median age 64 years, 50.5% female, BVAS range 0–30) and healthy controls27 ANCA-associated vasculitis (AAV) patients with follow-up
Participants
101 vs 92
Exposure
AAV patients vs healthy controls; active AAV vs remission
  • AAVn = 101
  • Healthy controls (HCs)n = 92reference
Outcome
Circulating mtDNA and nDNA copy numbers in platelet-free plasma (PCR)
Methodological detailsconsecutive patients, healthy controls
  • Consecutive patients
  • Healthy controls

Main finding

As reported in the abstract

  • Median mtDNA copies 13-fold higher in AAV than in HCs
  • nDNA concentrations did not differ between AAV and HCs

Observational data: associations, not effects.

Further findings

OutcomeValuesFold difference in median mtDNA copiesP value
mtDNA copies, active AAV (BVAS > 0) vs remission4-foldP = 0.03
Diagnostic performance of mtDNA, active AAV (BVAS > 0) vs HCs (ROC analysis)mtDNA quantification sensitivity 96.1% · specificity 98.9% · AUC 0.99

Correlation of mtDNA with BVAS

mtDNA vs BVAS, r (P = 0.002)
0.30
mtDNA, unlike nDNA, associated with AAV activity at multivariable analysis

Correlation of mtDNA changes with BVAS changes during follow-up (n = 27)

mtDNA changes vs BVAS changes, r (P = 0.002); CRP and ANCA titres did not correlate
0.56

Original publication

Mitochondrial DNA: a novel indicator of active inflammation in ANCA-associated vasculitides. Rheumatology (Oxford). Published 16 January 2023. doi:10.1093/rheumatology/kead015

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.